ArticleNeuropsychiatric disease and treatment2026
An Open-Label, Single-Arm Trial of Transcranial and Intranasal Photobiomodulation in Patients with Schizophrenia: A Study Protocol.
Risa Yamada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.